IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,199,000 | +241.8% | 90,276 | +85.4% | 0.20% | +273.6% |
| Q1 2019 | $936,000 | -83.2% | 48,700 | -87.5% | 0.05% | -87.6% |
| Q4 2018 | $5,558,000 | +664.5% | 389,536 | +649.1% | 0.43% | +1059.5% |
| Q3 2017 | $727,000 | -68.3% | 52,000 | -80.0% | 0.04% | -70.2% |
| Q2 2017 | $2,296,000 | +36.5% | 260,000 | 0.0% | 0.12% | +49.4% |
| Q1 2017 | $1,682,000 | -59.7% | 260,000 | -77.1% | 0.08% | -69.9% |
| Q4 2016 | $4,169,000 | -24.4% | 1,136,000 | -33.0% | 0.28% | -11.3% |
| Q3 2016 | $5,514,000 | – | 1,696,699 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |